N-[(1S)-2-(3,5-difluorophenyl)-1-[3-(4-ethylphenyl)-2-pyridinyl]ethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;N-[(1S)-2-(3,5-difluorophenyl)-1-[3-(2-methylphenyl)-2-pyridinyl]ethyl]-2-(5-hydroxy-1H-indol-3-yl)acetamide;N-[(1S)-2-(3,5-difluorophenyl)-1-[3-(2-methylphenyl)-2-pyridinyl]ethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;N-[(1S)-1-[3-(4-ethylphenyl)-2-pyridinyl]-2-(3-fluorophenyl)ethyl]-2-(5-hydroxy-1H-indol-3-yl)acetamide;N-[(1S)-1-[3-(4-ethylphenyl)-2-pyridinyl]-2-(3-fluorophenyl)ethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide

C153H139F17N18O7 — CID 157338389

IUPACN-[(1S)-2-(3,5-difluorophenyl)-1-[3-(4-ethylphenyl)-2-pyridinyl]ethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;N-[(1S)-2-(3,5-difluorophenyl)-1-[3-(2-methylphenyl)-2-pyridinyl]ethyl]-2-(5-hydroxy-1H-indol-3-yl)acetamide;N-[(1S)-2-(3,5-difluorophenyl)-1-[3-(2-methylphenyl)-2-pyridinyl]ethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;N-[(1S)-1-[3-(4-ethylphenyl)-2-pyridinyl]-2-(3-fluorophenyl)ethyl]-2-(5-hydroxy-1H-indol-3-yl)acetamide;N-[(1S)-1-[3-(4-ethylphenyl)-2-pyridinyl]-2-(3-fluorophenyl)ethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide
SMILESCCc1ccc(-c2cccnc2[C@H](Cc2cc(F)cc(F)c2)NC(=O)Cn2nc(C(F)(F)F)c3c2CCCC3)cc1.CCc1ccc(-c2cccnc2[C@H](Cc2cccc(F)c2)NC(=O)Cc2c[nH]c3ccc(O)cc23)cc1.CCc1ccc(-c2cccnc2[C@H](Cc2cccc(F)c2)NC(=O)Cn2nc(C(F)(F)F)c3c2CCCC3)cc1.Cc1ccccc1-c1cccnc1[C@H](Cc1cc(F)cc(F)c1)NC(=O)Cc1c[nH]c2ccc(O)cc12.Cc1ccccc1-c1cccnc1[C@H](Cc1cc(F)cc(F)c1)NC(=O)Cn1nc(C(F)(F)F)c2c1CCCC2
InChIInChI=1S/C31H29F5N4O.C31H30F4N4O.C31H28FN3O2.C30H27F5N4O.C30H25F2N3O2/c1-2-19-9-11-21(12-10-19)24-7-5-13-37-29(24)26(16-20-14-22(32)17-23(33)15-20)38-28(41)18-40-27-8-4-3-6-25(27)30(39-40)31(34,35)36;1-2-20-12-14-22(15-13-20)24-10-6-16-36-29(24)26(18-21-7-5-8-23(32)17-21)37-28(40)19-39-27-11-4-3-9-25(27)30(38-39)31(33,34)35;1-2-20-8-10-22(11-9-20)26-7-4-14-33-31(26)29(16-21-5-3-6-24(32)15-21)35-30(37)17-23-19-34-28-13-12-25(36)18-27(23)28;1-18-7-2-3-8-22(18)23-10-6-12-36-28(23)25(15-19-13-20(31)16-21(32)14-19)37-27(40)17-39-26-11-5-4-9-24(26)29(38-39)30(33,34)35;1-18-5-2-3-6-24(18)25-7-4-10-33-30(25)28(13-19-11-21(31)15-22(32)12-19)35-29(37)14-20-17-34-27-9-8-23(36)16-26(20)27/h5,7,9-15,17,26H,2-4,6,8,16,18H2,1H3,(H,38,41);5-8,10,12-17,26H,2-4,9,11,18-19H2,1H3,(H,37,40);3-15,18-19,29,34,36H,2,16-17H2,1H3,(H,35,37);2-3,6-8,10,12-14,16,25H,4-5,9,11,15,17H2,1H3,(H,37,40);2-12,15-17,28,34,36H,13-14H2,1H3,(H,35,37)/t2*26-;29-;25-;28-/m00000/s1
InChIKeyBGCKLKZEVSKKJL-IWWMKXSMSA-N
MW2664.88 g/mol
LogP32.40
Rot. Bonds38

About N-[(1S)-2-(3,5-difluorophenyl)-1-[3-(4-ethylphenyl)-2-pyridinyl]ethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;N-[(1S)-2-(3,5-difluorophenyl)-1-[3-(2-methylphenyl)-2-pyridinyl]ethyl]-2-(5-hydroxy-1H-indol-3-yl)acetamide;N-[(1S)-2-(3,5-difluorophenyl)-1-[3-(2-methylphenyl)-2-pyridinyl]ethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;N-[(1S)-1-[3-(4-ethylphenyl)-2-pyridinyl]-2-(3-fluorophenyl)ethyl]-2-(5-hydroxy-1H-indol-3-yl)acetamide;N-[(1S)-1-[3-(4-ethylphenyl)-2-pyridinyl]-2-(3-fluorophenyl)ethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide

N-[(1S)-2-(3,5-difluorophenyl)-1-[3-(4-ethylphenyl)-2-pyridinyl]ethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;N-[(1S)-2-(3,5-difluorophenyl)-1-[3-(2-methylphenyl)-2-pyridinyl]ethyl]-2-(5-hydroxy-1H-indol-3-yl)acetamide;N-[(1S)-2-(3,5-difluorophenyl)-1-[3-(2-methylphenyl)-2-pyridinyl]ethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;N-[(1S)-1-[3-(4-ethylphenyl)-2-pyridinyl]-2-(3-fluorophenyl)ethyl]-2-(5-hydroxy-1H-indol-3-yl)acetamide;N-[(1S)-1-[3-(4-ethylphenyl)-2-pyridinyl]-2-(3-fluorophenyl)ethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide (PubChem CID 157338389) has the molecular formula C153H139F17N18O7 and a molecular weight of 2664.88 g/mol. Its IUPAC name is N-[(1S)-2-(3,5-difluorophenyl)-1-[3-(4-ethylphenyl)-2-pyridinyl]ethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;N-[(1S)-2-(3,5-difluorophenyl)-1-[3-(2-methylphenyl)-2-pyridinyl]ethyl]-2-(5-hydroxy-1H-indol-3-yl)acetamide;N-[(1S)-2-(3,5-difluorophenyl)-1-[3-(2-methylphenyl)-2-pyridinyl]ethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;N-[(1S)-1-[3-(4-ethylphenyl)-2-pyridinyl]-2-(3-fluorophenyl)ethyl]-2-(5-hydroxy-1H-indol-3-yl)acetamide;N-[(1S)-1-[3-(4-ethylphenyl)-2-pyridinyl]-2-(3-fluorophenyl)ethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide.

Molecular Properties

Compound NameN-[(1S)-2-(3,5-difluorophenyl)-1-[3-(4-ethylphenyl)-2-pyridinyl]ethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;N-[(1S)-2-(3,5-difluorophenyl)-1-[3-(2-methylphenyl)-2-pyridinyl]ethyl]-2-(5-hydroxy-1H-indol-3-yl)acetamide;N-[(1S)-2-(3,5-difluorophenyl)-1-[3-(2-methylphenyl)-2-pyridinyl]ethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;N-[(1S)-1-[3-(4-ethylphenyl)-2-pyridinyl]-2-(3-fluorophenyl)ethyl]-2-(5-hydroxy-1H-indol-3-yl)acetamide;N-[(1S)-1-[3-(4-ethylphenyl)-2-pyridinyl]-2-(3-fluorophenyl)ethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide
PubChem CID157338389
Molecular FormulaC153H139F17N18O7
Molecular Weight2664.88 g/mol
Exact Mass2663.08
IUPAC NameN-[(1S)-2-(3,5-difluorophenyl)-1-[3-(4-ethylphenyl)-2-pyridinyl]ethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;N-[(1S)-2-(3,5-difluorophenyl)-1-[3-(2-methylphenyl)-2-pyridinyl]ethyl]-2-(5-hydroxy-1H-indol-3-yl)acetamide;N-[(1S)-2-(3,5-difluorophenyl)-1-[3-(2-methylphenyl)-2-pyridinyl]ethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;N-[(1S)-1-[3-(4-ethylphenyl)-2-pyridinyl]-2-(3-fluorophenyl)ethyl]-2-(5-hydroxy-1H-indol-3-yl)acetamide;N-[(1S)-1-[3-(4-ethylphenyl)-2-pyridinyl]-2-(3-fluorophenyl)ethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide
SMILESCCc1ccc(-c2cccnc2[C@H](Cc2cc(F)cc(F)c2)NC(=O)Cn2nc(C(F)(F)F)c3c2CCCC3)cc1.CCc1ccc(-c2cccnc2[C@H](Cc2cccc(F)c2)NC(=O)Cc2c[nH]c3ccc(O)cc23)cc1.CCc1ccc(-c2cccnc2[C@H](Cc2cccc(F)c2)NC(=O)Cn2nc(C(F)(F)F)c3c2CCCC3)cc1.Cc1ccccc1-c1cccnc1[C@H](Cc1cc(F)cc(F)c1)NC(=O)Cc1c[nH]c2ccc(O)cc12.Cc1ccccc1-c1cccnc1[C@H](Cc1cc(F)cc(F)c1)NC(=O)Cn1nc(C(F)(F)F)c2c1CCCC2
InChIInChI=1S/C31H29F5N4O.C31H30F4N4O.C31H28FN3O2.C30H27F5N4O.C30H25F2N3O2/c1-2-19-9-11-21(12-10-19)24-7-5-13-37-29(24)26(16-20-14-22(32)17-23(33)15-20)38-28(41)18-40-27-8-4-3-6-25(27)30(39-40)31(34,35)36;1-2-20-12-14-22(15-13-20)24-10-6-16-36-29(24)26(18-21-7-5-8-23(32)17-21)37-28(40)19-39-27-11-4-3-9-25(27)30(38-39)31(33,34)35;1-2-20-8-10-22(11-9-20)26-7-4-14-33-31(26)29(16-21-5-3-6-24(32)15-21)35-30(37)17-23-19-34-28-13-12-25(36)18-27(23)28;1-18-7-2-3-8-22(18)23-10-6-12-36-28(23)25(15-19-13-20(31)16-21(32)14-19)37-27(40)17-39-26-11-5-4-9-24(26)29(38-39)30(33,34)35;1-18-5-2-3-6-24(18)25-7-4-10-33-30(25)28(13-19-11-21(31)15-22(32)12-19)35-29(37)14-20-17-34-27-9-8-23(36)16-26(20)27/h5,7,9-15,17,26H,2-4,6,8,16,18H2,1H3,(H,38,41);5-8,10,12-17,26H,2-4,9,11,18-19H2,1H3,(H,37,40);3-15,18-19,29,34,36H,2,16-17H2,1H3,(H,35,37);2-3,6-8,10,12-14,16,25H,4-5,9,11,15,17H2,1H3,(H,37,40);2-12,15-17,28,34,36H,13-14H2,1H3,(H,35,37)/t2*26-;29-;25-;28-/m00000/s1
InChIKeyBGCKLKZEVSKKJL-IWWMKXSMSA-N
XLogP32.40
TPSA335.45 Ų
H-Bond Donors9
H-Bond Acceptors18
Rotatable Bonds38
Heavy Atoms195
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002664.88
LogP ≤ 532.40
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1018

Analyze N-[(1S)-2-(3,5-difluorophenyl)-1-[3-(4-ethylphenyl)-2-pyridinyl]ethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;N-[(1S)-2-(3,5-difluorophenyl)-1-[3-(2-methylphenyl)-2-pyridinyl]ethyl]-2-(5-hydroxy-1H-indol-3-yl)acetamide;N-[(1S)-2-(3,5-difluorophenyl)-1-[3-(2-methylphenyl)-2-pyridinyl]ethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;N-[(1S)-1-[3-(4-ethylphenyl)-2-pyridinyl]-2-(3-fluorophenyl)ethyl]-2-(5-hydroxy-1H-indol-3-yl)acetamide;N-[(1S)-1-[3-(4-ethylphenyl)-2-pyridinyl]-2-(3-fluorophenyl)ethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[(1S)-2-(3,5-difluorophenyl)-1-[3-(4-ethylphenyl)-2-pyridinyl]ethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;N-[(1S)-2-(3,5-difluorophenyl)-1-[3-(2-methylphenyl)-2-pyridinyl]ethyl]-2-(5-hydroxy-1H-indol-3-yl)acetamide;N-[(1S)-2-(3,5-difluorophenyl)-1-[3-(2-methylphenyl)-2-pyridinyl]ethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;N-[(1S)-1-[3-(4-ethylphenyl)-2-pyridinyl]-2-(3-fluorophenyl)ethyl]-2-(5-hydroxy-1H-indol-3-yl)acetamide;N-[(1S)-1-[3-(4-ethylphenyl)-2-pyridinyl]-2-(3-fluorophenyl)ethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide?
The IUPAC name of N-[(1S)-2-(3,5-difluorophenyl)-1-[3-(4-ethylphenyl)-2-pyridinyl]ethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;N-[(1S)-2-(3,5-difluorophenyl)-1-[3-(2-methylphenyl)-2-pyridinyl]ethyl]-2-(5-hydroxy-1H-indol-3-yl)acetamide;N-[(1S)-2-(3,5-difluorophenyl)-1-[3-(2-methylphenyl)-2-pyridinyl]ethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;N-[(1S)-1-[3-(4-ethylphenyl)-2-pyridinyl]-2-(3-fluorophenyl)ethyl]-2-(5-hydroxy-1H-indol-3-yl)acetamide;N-[(1S)-1-[3-(4-ethylphenyl)-2-pyridinyl]-2-(3-fluorophenyl)ethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide (CID 157338389) is N-[(1S)-2-(3,5-difluorophenyl)-1-[3-(4-ethylphenyl)-2-pyridinyl]ethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;N-[(1S)-2-(3,5-difluorophenyl)-1-[3-(2-methylphenyl)-2-pyridinyl]ethyl]-2-(5-hydroxy-1H-indol-3-yl)acetamide;N-[(1S)-2-(3,5-difluorophenyl)-1-[3-(2-methylphenyl)-2-pyridinyl]ethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;N-[(1S)-1-[3-(4-ethylphenyl)-2-pyridinyl]-2-(3-fluorophenyl)ethyl]-2-(5-hydroxy-1H-indol-3-yl)acetamide;N-[(1S)-1-[3-(4-ethylphenyl)-2-pyridinyl]-2-(3-fluorophenyl)ethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide.
What is the SMILES notation for N-[(1S)-2-(3,5-difluorophenyl)-1-[3-(4-ethylphenyl)-2-pyridinyl]ethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;N-[(1S)-2-(3,5-difluorophenyl)-1-[3-(2-methylphenyl)-2-pyridinyl]ethyl]-2-(5-hydroxy-1H-indol-3-yl)acetamide;N-[(1S)-2-(3,5-difluorophenyl)-1-[3-(2-methylphenyl)-2-pyridinyl]ethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;N-[(1S)-1-[3-(4-ethylphenyl)-2-pyridinyl]-2-(3-fluorophenyl)ethyl]-2-(5-hydroxy-1H-indol-3-yl)acetamide;N-[(1S)-1-[3-(4-ethylphenyl)-2-pyridinyl]-2-(3-fluorophenyl)ethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide?
The canonical SMILES for N-[(1S)-2-(3,5-difluorophenyl)-1-[3-(4-ethylphenyl)-2-pyridinyl]ethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;N-[(1S)-2-(3,5-difluorophenyl)-1-[3-(2-methylphenyl)-2-pyridinyl]ethyl]-2-(5-hydroxy-1H-indol-3-yl)acetamide;N-[(1S)-2-(3,5-difluorophenyl)-1-[3-(2-methylphenyl)-2-pyridinyl]ethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;N-[(1S)-1-[3-(4-ethylphenyl)-2-pyridinyl]-2-(3-fluorophenyl)ethyl]-2-(5-hydroxy-1H-indol-3-yl)acetamide;N-[(1S)-1-[3-(4-ethylphenyl)-2-pyridinyl]-2-(3-fluorophenyl)ethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide is CCc1ccc(-c2cccnc2[C@H](Cc2cc(F)cc(F)c2)NC(=O)Cn2nc(C(F)(F)F)c3c2CCCC3)cc1.CCc1ccc(-c2cccnc2[C@H](Cc2cccc(F)c2)NC(=O)Cc2c[nH]c3ccc(O)cc23)cc1.CCc1ccc(-c2cccnc2[C@H](Cc2cccc(F)c2)NC(=O)Cn2nc(C(F)(F)F)c3c2CCCC3)cc1.Cc1ccccc1-c1cccnc1[C@H](Cc1cc(F)cc(F)c1)NC(=O)Cc1c[nH]c2ccc(O)cc12.Cc1ccccc1-c1cccnc1[C@H](Cc1cc(F)cc(F)c1)NC(=O)Cn1nc(C(F)(F)F)c2c1CCCC2.
What is the InChIKey of N-[(1S)-2-(3,5-difluorophenyl)-1-[3-(4-ethylphenyl)-2-pyridinyl]ethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;N-[(1S)-2-(3,5-difluorophenyl)-1-[3-(2-methylphenyl)-2-pyridinyl]ethyl]-2-(5-hydroxy-1H-indol-3-yl)acetamide;N-[(1S)-2-(3,5-difluorophenyl)-1-[3-(2-methylphenyl)-2-pyridinyl]ethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;N-[(1S)-1-[3-(4-ethylphenyl)-2-pyridinyl]-2-(3-fluorophenyl)ethyl]-2-(5-hydroxy-1H-indol-3-yl)acetamide;N-[(1S)-1-[3-(4-ethylphenyl)-2-pyridinyl]-2-(3-fluorophenyl)ethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide?
The InChIKey is BGCKLKZEVSKKJL-IWWMKXSMSA-N. The full InChI is InChI=1S/C31H29F5N4O.C31H30F4N4O.C31H28FN3O2.C30H27F5N4O.C30H25F2N3O2/c1-2-19-9-11-21(12-10-19)24-7-5-13-37-29(24)26(16-20-14-22(32)17-23(33)15-20)38-28(41)18-40-27-8-4-3-6-25(27)30(39-40)31(34,35)36;1-2-20-12-14-22(15-13-20)24-10-6-16-36-29(24)26(18-21-7-5-8-23(32)17-21)37-28(40)19-39-27-11-4-3-9-25(27)30(38-39)31(33,34)35;1-2-20-8-10-22(11-9-20)26-7-4-14-33-31(26)29(16-21-5-3-6-24(32)15-21)35-30(37)17-23-19-34-28-13-12-25(36)18-27(23)28;1-18-7-2-3-8-22(18)23-10-6-12-36-28(23)25(15-19-13-20(31)16-21(32)14-19)37-27(40)17-39-26-11-5-4-9-24(26)29(38-39)30(33,34)35;1-18-5-2-3-6-24(18)25-7-4-10-33-30(25)28(13-19-11-21(31)15-22(32)12-19)35-29(37)14-20-17-34-27-9-8-23(36)16-26(20)27/h5,7,9-15,17,26H,2-4,6,8,16,18H2,1H3,(H,38,41);5-8,10,12-17,26H,2-4,9,11,18-19H2,1H3,(H,37,40);3-15,18-19,29,34,36H,2,16-17H2,1H3,(H,35,37);2-3,6-8,10,12-14,16,25H,4-5,9,11,15,17H2,1H3,(H,37,40);2-12,15-17,28,34,36H,13-14H2,1H3,(H,35,37)/t2*26-;29-;25-;28-/m00000/s1.
What are the key properties of N-[(1S)-2-(3,5-difluorophenyl)-1-[3-(4-ethylphenyl)-2-pyridinyl]ethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;N-[(1S)-2-(3,5-difluorophenyl)-1-[3-(2-methylphenyl)-2-pyridinyl]ethyl]-2-(5-hydroxy-1H-indol-3-yl)acetamide;N-[(1S)-2-(3,5-difluorophenyl)-1-[3-(2-methylphenyl)-2-pyridinyl]ethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;N-[(1S)-1-[3-(4-ethylphenyl)-2-pyridinyl]-2-(3-fluorophenyl)ethyl]-2-(5-hydroxy-1H-indol-3-yl)acetamide;N-[(1S)-1-[3-(4-ethylphenyl)-2-pyridinyl]-2-(3-fluorophenyl)ethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide?
N-[(1S)-2-(3,5-difluorophenyl)-1-[3-(4-ethylphenyl)-2-pyridinyl]ethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;N-[(1S)-2-(3,5-difluorophenyl)-1-[3-(2-methylphenyl)-2-pyridinyl]ethyl]-2-(5-hydroxy-1H-indol-3-yl)acetamide;N-[(1S)-2-(3,5-difluorophenyl)-1-[3-(2-methylphenyl)-2-pyridinyl]ethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;N-[(1S)-1-[3-(4-ethylphenyl)-2-pyridinyl]-2-(3-fluorophenyl)ethyl]-2-(5-hydroxy-1H-indol-3-yl)acetamide;N-[(1S)-1-[3-(4-ethylphenyl)-2-pyridinyl]-2-(3-fluorophenyl)ethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide has a molecular weight of 2664.88 g/mol, XLogP of 32.40, 38 rotatable bonds, 9 hydrogen bond donors, and 18 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(1S)-2-(3,5-difluorophenyl)-1-[3-(4-ethylphenyl)-2-pyridinyl]ethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;N-[(1S)-2-(3,5-difluorophenyl)-1-[3-(2-methylphenyl)-2-pyridinyl]ethyl]-2-(5-hydroxy-1H-indol-3-yl)acetamide;N-[(1S)-2-(3,5-difluorophenyl)-1-[3-(2-methylphenyl)-2-pyridinyl]ethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;N-[(1S)-1-[3-(4-ethylphenyl)-2-pyridinyl]-2-(3-fluorophenyl)ethyl]-2-(5-hydroxy-1H-indol-3-yl)acetamide;N-[(1S)-1-[3-(4-ethylphenyl)-2-pyridinyl]-2-(3-fluorophenyl)ethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide is sourced from PubChem (CID 157338389), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).